Influence of physical properties of carrier on the performance of dry powder inhalers

被引:133
作者
Peng, Tingting [1 ]
Lin, Shiqi [1 ]
Niu, Boyi [1 ]
Wang, Xinyi [1 ]
Huang, Ying [1 ]
Zhang, Xuejuan [1 ]
Li, Ge [2 ]
Pan, Xin [1 ]
Wu, Chuanbin [1 ,3 ]
机构
[1] Sun Yat Sen Univ, Sch Pharmaceut Sci, Guangzhou 510006, Guangdong, Peoples R China
[2] Guangzhou Neworld Pharm Co Ltd, Guangzhou 51006, Guangdong, Peoples R China
[3] Guangdong Res Ctr Drug Delivery Syst, Guangzhou 510006, Guangdong, Peoples R China
关键词
Carrier; Particle size; Morphology; Surface roughness; Performance; Dry powder inhaler; SPRAY-DRIED MANNITOL; PULMONARY DRUG-DELIVERY; MODIFIED GLASS-BEADS; SALBUTAMOL SULFATE; IN-VITRO; FLUTICASONE PROPIONATE; AEROSOL PERFORMANCE; RELATIVE-HUMIDITY; SURFACE CHARACTERISTICS; PARTICLE FORMULATION;
D O I
10.1016/j.apsb.2016.03.011
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Dry powder inhalers (DPIs) offer distinct advantages as a means of pulmonary drug delivery and have attracted much attention in the field of pharmaceutical science. DPIs commonly contain micronized drug particles which, because of their cohesiveness and strong propensity to aggregate, have poor aerosolization performance. Thus carriers with a larger particle size are added to address this problem. However, the performance of DPIs is profoundly influenced by the physical properties of the carrier, particularly their particle size, morphology/shape and surface roughness. Because these factors are interdependent, it is difficult to completely understand how they individually influence DPI performance. The purpose of this review is to summarize and illuminate how these factors affect drug carrier interaction and influence the performance of DPIs. (C) 2016 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V.
引用
收藏
页码:308 / 318
页数:11
相关论文
共 91 条
[11]   The effect of carrier surface treatment on drug particle detachment from crystalline carriers in adhesive mixtures for inhalation [J].
Dickhoff, B. H. J. ;
de Boer, A. H. ;
Lambregts, D. ;
Frijlink, H. W. .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2006, 327 (1-2) :17-25
[12]   Carrier-based dry powder inhalation: Impact of carrier modification on capsule filling processability and in vitro aerodynamic performance [J].
Faulhammer, Eva ;
Wahl, Verena ;
Zellnitz, Sarah ;
Khinast, Johannes G. ;
Paudel, Amrit .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2015, 491 (1-2) :231-242
[13]   The influence of carrier roughness on adhesion, content uniformity and the in vitro deposition of terbutaline sulphate from dry powder inhalers [J].
Flament, MP ;
Leterme, P ;
Gayot, A .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2004, 275 (1-2) :201-209
[14]   A proposed definition of the 'activity' of surface sites on lactose carriers for dry powder inhalation [J].
Grasmeijer, Floris ;
Frijlink, Henderik W. ;
de Boer, Anne H. .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2014, 56 :102-104
[15]   New Mechanisms to Explain the Effects of Added Lactose Fines on the Dispersion Performance of Adhesive Mixtures for Inhalation [J].
Grasmeijer, Floris ;
Lexmond, Anne J. ;
van den Noort, Maarten ;
Hagedoorn, Paul ;
Hickey, Anthony J. ;
Frijlink, Henderik W. ;
de Boer, Anne H. .
PLOS ONE, 2014, 9 (01)
[16]   Influence of fine lactose and magnesium stearate on low dose dry powder inhaler formulations [J].
Guchardi, R. ;
Frei, M. ;
John, E. ;
Kaerger, J. S. .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2008, 348 (1-2) :10-17
[17]   Influence of carrier particle size, carrier ratio and addition of fine ternary particles on the dry powder inhalation performance of insulin-loaded PLGA microcapsules [J].
Hamishehkar, Hamed ;
Emami, Jaber ;
Najafabadi, Abdolhossien Rouholamini ;
Gilani, Kambiz ;
Minaiyan, Mohsen ;
Mandavi, Hamid ;
Nokhodchi, Ali .
POWDER TECHNOLOGY, 2010, 201 (03) :289-295
[18]  
Harper W.R., 1998, CONTACT FRICTIONAL E
[19]   Inhalation performance of pollen-shape carrier in dry powder formulation: Effect of size and surface morphology [J].
Hassan, Meer Saiful ;
Lau, Raymond .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2011, 413 (1-2) :93-102
[20]  
Hassan MS, 2010, CURR PHARM DESIGN, V16, P2377